Arctiin targets oxidative stress and inflammation, restores Neuregulin-1, and improves neurobehavioral outcomes in neonatal hypoxic-ischemic brain injury

Current Research in Pharmacology and Drug Discovery · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles